A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes

✍ Scribed by Olivier Rascol; Cheryl J Fitzer-Attas; Robert Hauser; Joseph Jankovic; Anthony Lang; J William Langston; Eldad Melamed; Werner Poewe; Fabrizio Stocchi; Eduardo Tolosa; Eli Eyal; Yoni M Weiss; C Warren Olanow

• Book ID: 114409780
• Publisher: The Lancet
• Year: 2011
• Tongue: English
• Weight: 190 KB
• Volume: 10
• Category: Article
• ISSN: 1474-4465
• DOI: 10.1016/s1474-4422(11)70073-4